Clinical Trials Browser

Carcinoma, Hepatocellular × Adjuvants, Pharmaceutic × Clear all

NCT06218511 2025-12-22

A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)

Phase 1 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT04727307 2025-09-30

AB-LATE02

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases